Nuritas

11 articles about Nuritas

• Nuritas™ Announces North American Headquarters, CEO to Relocate to US

  5/17/2022

  Nuritas, a biotechnology company using AI to revolutionize the discovery of untapped, natural, bioactive peptides, announced it will build its North American headquarters in Connecticut, near Yale University.

• 

  Using AI to Find Peptide Therapeutics for COVID-19

  4/24/2020

  Nuritas, a biotech company that focuses on leveraging artificial intelligence (AI) to discover therapeutic peptides, is joining the fight by tasking their powerful AI platform to find peptides that can be used as therapeutics for COVID-19.

• Nuritas Leverages AI Platform to Identify Therapeutic Peptides for the Treatment of COVID-19

  4/22/2020

  Focused on Creating ‘Cocktail’ of Therapeutic Peptides with both Antiviral and Cytokine Regulation Qualities to Modify Inflammatory Response Associated with COVID-19 Respiratory Damage Grant Funded by Partnership for Advanced Computing in Europe

• Nuritas and Stonehaven Incubate Sign Partnership Agreement to Bring Artificial Intelligence to Animal Health

  7/25/2019

  Nuritas and Stonehaven Incubate have announced a new collaboration which will see them join forces as part of a newly created joint venture

• Nuritas and SFI BEACON Bioeconomy Research Centre to investigate oral bioavailability, a holy grail of the pharmaceutical industry

  2/12/2019

  The public-private research partnership, led by Prof. David Brayden, a senior scientist at BEACON based in UCD and Dr Nora Khaldi, CSO & Founder of Nuritas, has the potential to be a game changer for the biopharma industry and patients alike.

• Nestlé and Nuritas to Work Together on Discovery of Food-Derived Bioactive Peptides Through Artificial Intelligence

  2/8/2018

  Nestle and Nuritas have entered into a collaboration aiming at discovering bioactive peptide networks within specific target areas of significant value.

• 

  Nuritas Raises €16 Million in Series A Funding Using Artificial Intelligence to Unlock Bioactive ...

  12/20/2017

  Nuritas today announced the close of a circa €16 million Series A funding round led by Chicago-based Cultivian Sandbox Ventures.

• Nuritas Founder Wins Rising Star Award At The National Tech Excellence Awards

  5/19/2017

• Nuritas Founder Wins Woman Of The Decade In Business And Leadership Award

  1/30/2017

• BASF Release: Company And Nuritas To Work Together On Delivering Next Generation Peptide Ingredients Through Artificial Intelligence

  1/18/2017

• Nuritas Appoints Former Novartis AG Global Leader As Chairman

  1/25/2016